Numerical and experimental study of delamination in laminated composites
2010
0 views
0 downloads
Advisor: Prof. Dr. Mehmet Alaeddin Akgün
Abstract (EN)
In this study, delamination growth in a double cantilever beam (DCB) specimen, which is used to measure critical strain energy release rate under a mode I type of loading, was investigated experimentally and numerically. In addition, delamination growth in mixed mode beam (MMB) specimens was tested to measure critical strain energy release rates under mixed mode I and mode II types of loading and fatigue tests were conducted on tapered laminates.The material in all cases was carbon fiber reinforced epoxy. The laminates were manufactured from UD (Unidirectional) carbon tapes. Delamination growth was simulated with a fracture mechanics approach, virtual crack closure technique (VCCT), using the finite element method. In order to implement the VCCT method element?killing strategy was used. This provided a means to handle moving meshes during delamination propagation. Simple tension tests and three point bending tests were conducted as well to determine basic material properties.
Author
Ender Alper Top
How to Cite
Ender Alper Top (Master Thesis). Numerical and experimental study of delamination in laminated composites, 2010, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)